Nr1d2 also represses the expression of hepatic Apoc3 mRNA, a risk factor for atherosclerosis [38], and hepatic Insig1 overexpression reduces lipogenesis via decreased expression of Srebp1c mRNA and its target enzymes [39]. This evidence concerns the gene SREBF1 and atherosclerosis.